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summAry – Streptococcus agalactiae is one of the uropathogens responsible for urinary tract 
infections (uti) in children, pregnant women, and elderly people with chronic underlying diseases. 
This study was performed to determine the prevalence of urinary tract isolates of group B streptoco-
cci (GBs) in a group of females referred to a referral university hospital in iran. in this retrospec-
tive cross-sectional study, urine analysis and urine culture results of all female subjects referred to 
the laboratory of the rasoul-e-Akram hospital, tehran, iran in 2010 were reviewed. Bacteriuria, 
colony count, pyuria and demographic data of patients were also evaluated. in this study, 10,256 
females were investigated; 2061 (20.1%) of them had positive urine cultures. GBs was the isolated 
microorganism in 184 (8.92%) cases, yielding a prevalence of 1.79% in total study population. The 
mean age of subjects with positive GBs cultures was 48.24±18.8 years, with a higher prevalence 
recorded in the 51-60 and 21-30 age groups. The highest rates of cultures positive for GBs were seen 
in december and January. GBs was found to be sensitive to the following antibiotics: cephalothin 
(100%), norfloxacin (96.9%), ampicillin (96%), nitrofurantoin (95.5%), and vancomycin (95%). in 
this study, GBs showed greatest resistance to tetracycline (81.6%) and co-trimoxazole (68.9%). in 
conclusion, the prevalence of GBs in females with suspected uti is relatively low; however, atten-
tion to the age and susceptibility pattern of antibiotic treatment for uti caused by this microorga-
nism is necessary.
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Introduction
Group B streptococci (GBs) are considered as one 
of the main causes of infections in neonates, pregnant 
women, and the elderly with chronic diseases1,2. The 
most common sites at which GBs are found are the 
vagina, especially in pregnant women, urinary tract 
and colon3. Bacterial colonization is seen in about 10% 
of non-pregnant women and 25% of pregnant individ-
uals3, while approximately 60% of the neonates whose 
mothers had colonization of the bacteria remain colo-
nized with the bacteria obtained from their mothers4.
urinary tract infections (uti) caused by GBs 
include asymptomatic bacteriuria, cystitis, pyelone-
phritis, urethritis and urosepsis5. Asymptomatic bac-
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teriuria caused by GBs is more common among preg-
nant women, while the cases who are at risk of cystitis 
by GBs are mostly the elderly and the patients with 
suppressed immune system1,6. Although background 
pathogenesis leading to acute uti caused by GBs is 
unknown, diabetes mellitus and chronic renal failure 
are considered as risk factors7. 
There are only few and limited studies to deter-
mine the role of GBs in uti in non-pregnant adults. 
Thus, the present study was conducted to investigate 
the prevalence of this microorganism isolated from 
urine of female individuals referred to the laboratory 
of rasoul-e-Akram hospital, tehran, iran, and to 
determine resistance and sensitivity of the bacteria to 
antibiotics.
Materials and Methods
This cross-sectional retrospective study included 
all females who had been referred to the labora-
tory of rasoul-e-Akram hospital for urine analysis 
(uA) and urine culture (uC) in 2010. The sampling 
method was a census; the samples that were positive 
for GBs were investigated thoroughly. All the sub-
jects were required to collect the middle sterile part 
of the urine. The urine samples were cultivated on 
blood agar and macConkey media. After 48 hours, 
the ones with pure culture of 103 or more colonies per 
ml were considered positive. sensitivity of the mi-
croorganism to the antibiotics including ampicillin, 
cephalothin, cefazolin, tetracycline, nitrofurantoin, 
norfloxacin, co-trimoxazole and vancomycin was 
determined. demographic information including 
the age of the subjects, the month and the season 
of performing the test, the number of bacteria and 
white blood cells (WBC) in the urine, resistance and 
sensitivity to antibiotics reported by uC were all re-
corded in a checklist. 
Results
GBS positivity
in this study, 10,256 female subjects referred to 
the hospital were investigated; 2,061 (20.09%) of 
them had positive urine culture, 184 (8.92%) positive 
for GBs, yielding a prevalence of 1.79% in total study 
population. 
Seasonal variations
The highest rates of cultures positive for GBs were 
seen in december (21 cases, 11.4%) and January (21 
cases, 11.4%), followed by July (20 cases, 10.9%) and 
August (19 cases, 10.3%), while the lowest rates were 
noticed in April (9 cases, 4.9%) and february (10 cas-
es, 5.4%).
Age distribution
The mean age of the subjects with culture positive 
for GBs was 48.24±18.8 years. The highest prevalence 
was recorded in the 51-60 (26.1%) and 21-30 (17.4%) 
age groups.
Colony count
The colony count of positive cultures was 10³ in 
13 (7.1%), between 10³ and 104 in 65 (35.3%), 104 to 
5×104 in 73 (39.7%), 5×104 to 105 in 15 (8.2%), and 
more than 105 in 18 (9.8%) cases.
Urinalysis
The number of bacteria counted in patient uA 
was as follows: rare in 57 (31%), few in 89 (48.4%), 
moderate in 29 (15.6%) and many in 9 (5%) cases. The 
mean WBC reported by uA of the patients positive 
for GBs was 6.6±10.1 (ranging from 0 to 50). most 
of the study subjects (154 cases, 83.7%) showed WBC 
count less than 10, 18 (9.8%) cases between 10 and 20, 
and 12 (6.5%) cases more than 20. 
Antibiotic sensitivity report
The results of antibiotic sensitivity testing carried 
out to determine sensitivity and resistance to antibi-
otics in cases positive for GBs were as follows: the 
microorganism was most sensitive to cephalothin 
(100%), norfloxacin (96.9%), ampicillin (96%), nitro-
furantoin (95.5%) and vancomycin (95%), while show-
ing highest resistance to tetracycline (81.6%) and co-
trimoxazole (68.9%) (table 1).
Discussion
This study showed that positive culture for GBs 
was found in less than 2 percent of all female subjects 
and about 9% in all females with positive culture. A 
previous study by munoz et al. on 24,906 urine sam-
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ples over a period of 19 months showed that 4482 
cases had positive culture; among them 22% revealed 
streptococcus species and GBs was isolated from only 
92 (2%) cases7. in another study by ulett et al. from 
2009, GBs was detected in the urine culture of 387 
(1.1%) out of 34,367 studied subjects5, which is in 
agreement with the results of our study.
middle-aged women seem to be the most com-
mon group susceptible to GBs uti7. The mean age of 
individuals positive for GBs was also 48 years in our 
study. our study showed that only 10% of the patients 
had a colony count of more than 105. in most of the 
cases, bacteriuria was less than moderate. most of the 
subjects did not show pyuria. however, in the study 
by munoz et al., the GBs colony count was more 
than 105 in urine culture of 63% of the subjects and 
urine analysis revealed pyuria in 60% of patients. The 
colony count of more than 105 and pyuria were more 
common among symptomatic patients than in asymp-
tomatic ones7. The cause of this difference could be 
attributed to the study population. in other studies, 
subjects with symptoms or signs of uti were investi-
gated; however, in this study, all cases that underwent 
uA and uC regardless of having or not having clini-
cal manifestations were enrolled.
The present study indicated that GBs was sensitive 
to cephalothin, norfloxacin, ampicillin, nitrofurantoin 
and vancomycin; therefore, treatment with ampicillin 
or cephalothin was recommended. resistance to tet-
racycline and co-trimoxazole has also been reported 
in other studies5. developing an orientation towards 
antibiotic resistance might show colony distribution 
and horizontal transfer of resistance genes among 
GBs, which mostly happens in certain serotypes of 
GBs8.
in conclusion, GBs is considered as a urinary 
pathogen with a prevalence of 1.7% according to this 
study. This microorganism is mostly seen in middle-
aged women, especially between 51 and 60 years of 
age. more than 90% of the cases with positive culture 
had a colony count less than 105 and low bacteriuria 
and pyuria. The study revealed that GBs was sensitive 
to cephalothin, norfloxacin, ampicillin, nitrofurantoin 
and vancomycin, but resistant to tetracycline and co-
trimoxazole.
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tetracycline 33 (18.4%) 146 (81.6%) 179
norfloxacin 157 (96.9%) 5 (3.1%) 162
Co-trimoxazole 57 (31.1%) 126 (68.9%) 183
Vancomycin 172 (95%) 9 (5%) 181
nitrofurantoin 150 (95.5%) 7 (4.5%) 157
Cefazolin 105 (86.8%) 16 (13.2%) 121
Ampicillin 167 (96%) 7 (4%) 174
Cephalothin 45 (100%) 0 45
Table 1. Antimicrobial susceptibility pattern of positive 
group B streptococcus isolates from urine cultures
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sažetak
iZolAti strePtoKoKA GruPe B u moKrAĆi i nJihoVA AntimiKroBnA osJetlJiVost u 
sKuPini irAnsKih ŽenA: uČestAlost i seZonsKe rAZliKe 
N. Shayanfar, M. Mohammadpour, S.A. Hashemi-Moghadam, M.T. Haghi Ashtiani, A. Zare Mirzaie i N. Rezaei 
Streptococcus agalactiae je jedan od uropatogena odgovornih za infekcije mokraćnog sustava kod djece, trudnica i starijih 
osoba s kroničnim osnovnim bolestima. Cilj ove studije bio je utvrditi učestalost izolata streptokoka grupe B u mokraćnom 
sustavu skupine žena upućenih u referentnu sveučilišnu bolnicu u iranu. u ovoj retrospektivnoj studiji obrađeni su rezul-
tati analize mokraće i kulture mokraće svih ženskih osoba upućenih u laboratorij Bolnice rasoul-e-Akram u teheranu, 
iran tijekom 2010. godine. obrađeni su i podaci o bakteriuriji, broju kolonija, piuriji, te demografski podaci svih bolesnica. 
od ukupno 10.256 ispitanih žena pozitivna kultura mokraće utvrđena je u 2061 (20,1%) žene. streptokok grupe B bio je 
izolirani mikroorganizam u 184 (8,92%) slučajeva, dok je njegova ukupna učestalost u čitavoj ispitivanoj populaciji bila 
1,79%. srednja dob žena s pozitivnom kulturom streptokoka grupe B bila je 48,24±18,8 godina, s većom učestalošću u 
dobnim skupinama od 51-60 i 21-30 godina. najviše stope pozitivnih kultura streptokoka grupe B zabilježene su u prosin-
cu i siječnju, a mikroorganizam je pokazao osjetljivost na slijedeće antibiotike: cefalotin (100%), norfloksacin (96,9%), am-
picilin (96%), nitrofurantoin (95,5%) i vankomicin (95%). u ovoj studiji je streptokok grupe B pokazao najveću otpornost 
na tetraciklin (81,6%) i kotrimoksazol (68,9%). Zaključuje se kako je učestalost streptokoka grupe B kod žena sa sumnjom 
na infekciju mokraćnog sustava relativno niska, međutim, pozornost treba posvetiti dobi bolesnice i profilu osjetljivosti 
antibiotske terapije za infekciju mokraćnog sustava uzrokovanu ovim mikroorganizmom.
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